AutoGenomics handles TB Crisis with Genetic Drug Resistance Test

MDR-TB (Multidrug Resistant TB) is a type of mycobacterium tuberculosis
that is resistant to at least the two main first-line TB drugs - isoniazid
and rifampicin.

The ability to rapidly verify an active MTB infection and determine
its resistance to first line antibiotics is essential to isolating and
eventually managing both the patient and individuals who may have been
exposed.

XDR-TB is MDR-TB that is also resistant to three or more drugs.

AutoGenomics has taken firm initiatives to combat the Tuberculosis Crisis with this Genetic Drug Resistance Test that AutoGenomics is here to promote and support with all required resources so as to efficiently comba the TB crises.